The Atrial Fibrillation Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market size for atrial fibrillation devices has experienced significant growth recently. It was valued at $7.69 billion in 2024 and is predicted to increase to $8.60 billion in 2025. This represents a compound annual growth rate (CAGR) of 11.8%.
The Atrial Fibrillation Devices Global Market is predicted to expand rapidly, reaching a value of $13.28 billion by 2029. This represents a compound annual growth rate (CAGR) of 11.5%.
Download Your Free Sample of the 2025 Atrial Fibrillation Devices Market Report and Uncover Key Trends Now!The key drivers in the atrial fibrillation devices market are:
• Rising incidents of cardiovascular diseases are fueling growth in the atrial fibrillation device market.
• The global increase in obesity and diabetes is expected to drive the market further.
• The widespread adoption of sedentary lifestyles and poor dietary habits are also key factors contributing to market growth.
• Atrial fibrillation devices' critical role in detecting, monitoring, and treating irregular heart rhythms is also driving their demand.
The atrial fibrillation devices market covered in this report is segmented –
1) By Device Type: Implantable Devices, External Devices, Catheter-Based Devices
2) By Product: Electrophysiology Ablation Catheters, Cardiac Monitors Or Implantable Loop Recorder, Electrophysiology Diagnostic Catheters, Mapping And Recording Systems, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, Other Products
3) By Technology: Radiofrequency, Cryotherapy, Ultrasound, Other Technologies
4) By Distribution Channel: Direct Sales, Distributors, Online Sales
5) By End-Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Other End Users
The key trends in the atrial fibrillation devices market are:
• Advancements in patient-centric clinical decision support tools are a notable trend.
• The market is heavily influenced by improvement in diagnostic accuracy and personalized treatment plans.
• The development and integration of digital tools to streamline clinician workflows are on the rise.
• The emphasis on reducing diagnostic errors and streamlining clinical decisions are crucial future trends.
Major players in the atrial fibrillation devices market are:
• Johnson & Johnson Services Inc.
• Abbott Laboratories
• Medtronic Public Limited Company
• Koninklijke Philips N.V.
• Boston Scientific Corporation
• Shanghai MicroPort EP MedTech Co. Ltd.
• Japan Lifeline Co. Ltd.
• Microlife Corporation
• AliveCor Inc.
• CardioFocus Inc.
• Imricor Medical Systems Inc.
• Kardium Inc.
• Stereotaxis Inc.
• Volta Medical
• Synaptic Medical Corporation
• Osypka AG
• CathRx Ltd.
• BIOTRONIK SE & Co. KG
• EP Solutions SA
• CardiacSense Ltd.
North America was the largest region in the atrial fibrillation devices market in 2024